Mangalam Drugs And Organics per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−₹24.16−₹28.05₹4.25−₹5.73
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹24.16−₹28.05₹4.25−₹5.73
₹65.11₹65.11₹94.12₹85.79
₹146.85₹146.66₹201.05₹232.87
—₹2.64₹26.91−₹7.00
−₹4.88−₹4.88₹14.15−₹7.00
1.61.61.61.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MANGALAM₹29.11

Mangalam Drugs And Organics Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMLASAVINEETLABORTINGLOBEKREBSBIOALPABALPHARMANATCAPSUQMcap ₹46.1 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS—-5.734.25-28.05-24.16
Diluted EPS—-5.734.25-28.05-24.16
Book Value per Share—85.7994.1265.1165.11
Revenue per Share—232.87201.05146.66146.85
Cash Flow per Share—-7.0026.912.64—
Free Cash Flow per Share—-7.0014.15-4.88-4.88
Shares Outstanding (cr)—1.61.61.61.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.